BACKGROUND
Topical β-blockers are commonly prescribed for primary open-angle glaucoma. Existing research is limited regarding respiratory or cardiovascular events that may result from using these topical β-blockers.
OBJECTIVE
To evaluate inpatient and outpatient service encounters and payments associated with the topical adjunctive use of the β-blocker timolol for glaucoma.
STUDY DESIGN
Retrospective data analysis using 2004-2011 IMS Lifelink Health Plan Claims Database.
PATIENTS… CONTINUE READING